Vertex Pharmaceuticals Inc banner

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 446.54 USD 0.76% Market Closed
Market Cap: $113.4B

Wall Street
Price Targets

VRTX Price Targets Summary
Vertex Pharmaceuticals Inc

Wall Street analysts forecast VRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRTX is 557.95 USD with a low forecast of 333.3 USD and a high forecast of 673.05 USD.

Lowest
Price Target
333.3 USD
25% Downside
Average
Price Target
557.95 USD
25% Upside
Highest
Price Target
673.05 USD
51% Upside
Vertex Pharmaceuticals Inc Competitors:
Price Targets
AFYA
Afya Ltd
14% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
1% Upside
APA
APA Corp (US)
-26% Downside

Revenue
Forecast

17% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

24% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
24% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's operating income is 24%. The projected CAGR for the next 3 years is 17%.

Net Income
Forecast

42% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
42% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRTX's stock price target?
Price Target
557.95 USD

According to Wall Street analysts, the average 1-year price target for VRTX is 557.95 USD with a low forecast of 333.3 USD and a high forecast of 673.05 USD.

What is Vertex Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 11%.

What is Vertex Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
17%

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's operating income is 24%. The projected CAGR for the next 3 years is 17%.

What is Vertex Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
17%

For the last 14 years the compound annual growth rate for Vertex Pharmaceuticals Inc's net income is 42%. The projected CAGR for the next 3 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett